<?xml version="1.0"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/"><rdf:Description rdf:about="https://dirros.openscience.si/IzpisGradiva.php?id=29893"><dc:title>Treatment of foreign body granulomas with combined enzyme therapy</dc:title><dc:creator>Castelanich,	Desirée Giselle	(Avtor)
	</dc:creator><dc:creator>Pascuzzi,	Delfina	(Avtor)
	</dc:creator><dc:creator>López Berroa,	Jorge	(Avtor)
	</dc:creator><dc:subject>granuloma</dc:subject><dc:subject>combined enzyme treatment</dc:subject><dc:subject>collagenase</dc:subject><dc:subject>hyaluronidase</dc:subject><dc:subject>lipase</dc:subject><dc:description>Introduction: Granulomas are focal aggregates of inflammatory cells that form in response to a persistent inflammatory stimulus. Available therapies include surgical and nonsurgical management, and current evidence is based on case series or case reports. Methods: Two case reports of foreign body granulomas treated with a combination of recombinant enzymes (hyaluronidase, collagenase, and lipase of bacterial origin) are presented. Results: Following three sessions of combined enzyme treatment with a scheduled protocol, both patients showed clinical improvement without any reported adverse events. Conclusions: Combined enzyme therapy is an effective, safe, minimally invasive, innovative approach for the treatment of foreign body granulomas.</dc:description><dc:publisher>Združenje slovenskih dermatovenerologov</dc:publisher><dc:date>2025</dc:date><dc:date>2026-06-09 08:37:46</dc:date><dc:type>Neznano</dc:type><dc:identifier>29893</dc:identifier><dc:language>sl</dc:language></rdf:Description></rdf:RDF>
